Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 12-2023 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -281,890 | -244,943 | -177,214 | -341,415 | 124,838 |
| Depreciation Amortization | 55,967 | 44,995 | 32,637 | 54,379 | 93,565 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 1,201 |
| Accounts receivable | N/A | -15,009 | -16,904 | N/A | -18,126 |
| Accounts payable and accrued liabilities | N/A | 5,054 | 2,623 | N/A | N/A |
| Other Working Capital | -29,067 | -22,099 | -5,301 | -7,129 | 70,051 |
| Other Operating Activity | 9,791 | 25,724 | 27,308 | 18,065 | -11,852 |
| Operating Cash Flow | $-245,199 | $-206,278 | $-136,851 | $-276,100 | $259,677 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 61,376 | 61,376 | N/A | -84 |
| PPE Investments | -8,444 | -6,154 | -4,326 | -22,319 | -744,094 |
| Other Investing Activity | 61,376 | 0 | 0 | 237,093 | 1,252 |
| Investing Cash Flow | $52,932 | $55,222 | $57,050 | $214,774 | $-742,926 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 199,978 | 199,978 | N/A | 1,221,888 |
| Debt Repayment | N/A | -136 | -110 | N/A | -707,890 |
| Common Stock Issued | N/A | 1,258 | 603 | N/A | 1,764 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -12,788 |
| Dividend Paid | 0 | N/A | N/A | 0 | -22,217 |
| Other Financing Activity | 200,292 | -1,034 | -492 | 10,132 | -1,584 |
| Financing Cash Flow | $200,292 | $200,066 | $199,979 | $10,132 | $479,173 |
| Exchange Rate Effect | -4 | -3 | 13 | 62 | -114 |
| Beginning Cash Position | 60,007 | 60,007 | 60,007 | 111,139 | 66,502 |
| End Cash Position | 68,028 | 109,014 | 180,198 | 60,007 | 62,312 |
| Net Cash Flow | $8,021 | $49,007 | $120,191 | $-51,132 | $-4,190 |
| Free Cash Flow | |||||
| Operating Cash Flow | -245,199 | -206,278 | -136,851 | -276,100 | 259,677 |
| Capital Expenditure | N/A | -6,154 | -4,326 | N/A | -821,900 |
| Free Cash Flow | -245,199 | -212,432 | -141,177 | -276,100 | -562,223 |